Date: 02 Aug 2018
Results from a recent study by a team of clinicians from Singapore validates the reliability of SHG microscopy – by HistoIndex’s Genesis®200 – as an automated and accurate method for fibrosis staging. This assessment tool adds significant value to a histopathologist’s efficiency and reliability in his/her routine clinical practice.Read More
Date: 04 Jul 2018
[Report by LiverSupport.com] Doctors and researchers agree that eating a well balanced diet containing the proper number of calories and an appropriate ratio of carbohydrates, proteins and fats are important for your overall health. For people with impaired liver function, proper nutrition takes on increasing importance. Eating liver friendly recipes not only helps protect and support your liver, but also helps your liver function better and regenerate new, healthy liver cells.Read More
Date: 27 Jun 2018
[Report by Healio] Results of a recent study showed that nonalcoholic steatohepatitis was the most rapidly growing cause of hepatocellular carcinoma among U.S. patients listed for liver transplantation.Read More
Date: 19 Jun 2018
[Report by Patient Worthy] Involved in the awareness and medical developments around NASH is HistoIndex. HistoIndex is committed, as their CEO explains, to meeting both the treatment and diagnostic needs of the NASH community. One path to this involves the development of “an integrated tissue diagnostics tool” that allows researchers to accurately track the effect of treatment in clinical trials.Read More
Date: 18 Jun 2018
[Report by Times of San Diego] Popular news anchor Brian Christie recounts his experience upon hearing of his NASH diagnosis, and how it is a growing health concern that people should be wary about.Read More
Date: 15 May 2018
[Story on EurekAlert] A University of Leeds study has found that majority of children in the cohort - with non-alcoholic fatty liver disease - had insufficient vitamin D levels throughout the 12-month period and severe vitamin D deficiency during winter.Read More
Date: 09 May 2018
Story by HistoIndex
Fibrous septa have been regarded as an important parameter in fibrosis progression and regression, and are clinically important in tracking treatment efficacy.
With septa width and other similar parameters seen in chronic liver diseases like NASH, will the dual combination of this classification method and HistoIndex's multiphoton digital pathology system be potentially advantageous in quantifying fibrosis regression in NASH clinical trials?Read More
Date: 09 May 2018
Brand new NAFLD & NASH Educational video by the NASH Education Program: “Biopsy: the gold standard for NASH Diagnosis” now available on YouTube!
Share to spread awareness!#NASHedu
Date: 08 May 2018
[Report by Michigan Health] After a lifetime of struggle, Edwen Lopez faced his biggest challenge: receiving a liver transplant. A Michigan Medicine transplant team was ready to help him win.
Lopez was diagnosed with stage 4 nonalcoholic steatohepatitis cirrhosis, better known as NASH disease, in 2015.Read More